Concepedia

Moheb Nasr

MN

Statistics

Publications

24

Citations

2.4K

H-Index

19

Active since

1986

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Massachusetts Institute of Technology

GlaxoSmithKline (United States)

Snowdon (United States)

Moheb Nasr is an author at United States Food and Drug Administration specializing in pharmacy, analytical chemistry, and pharmaceutics.

ORCID

Publications per year

1986–2019

24

Publications

24

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

Marco Guerrini, Daniela Beccati, Zachary Shriver et al. · Nature Biotechnology · 2008 · 617 citations

, , +7

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

Takashi Kishimoto, Karthik Viswanathan, Tanmoy Ganguly et al. · New England Journal of Medicine · 2008 · 616 citations · Full text

, , +12

Regulatory and Quality Considerations for Continuous Manufacturing May 20–21, 2014 Continuous Manufacturing Symposium

Gretchen M. Allison, Yanxi Tan Cain, Charles L. Cooney et al. · Journal of Pharmaceutical Sciences · 2015 · 176 citations

, , +17

Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice

Moheb Nasr, Markus Krumme, Yoshihiro Matsuda et al. · Journal of Pharmaceutical Sciences · 2017 · 137 citations

, , +14

Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen

Clive Badman, Charles L. Cooney, Alastair J. Florence et al. · Journal of Pharmaceutical Sciences · 2019 · 117 citations · Full text

, , +11

1–5 of 24